Amyotrophic Lateral Sclerosis
InnoCentive posts $1 million seeker challenge for biomarker discovery
Published in Healthcare Mergers, Acquisitions and Ventures Week, December 16th, 2006
"This important challenge, identifying an ALS 'biomarker,' is an effort to identify a specific measurement for the disease that can aid in detection and response to therapy," said Jill A. Panetta, PhD, InnoCentive's chief scientific officer.
"Valid biomarkers will enhance our understanding of the pathological process in ALS and our ability to gauge treatment efficacy," said Robert H. Brown, MD, DPhil. Brown is a member of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Acute Bronchitis
Virginia Commonwealth researchers report antibiotics unnecessary for bronchitis - Age-Related Macular Degeneration
Cellgate initiates phase I clinical study for eye disease - Age-Related Macular Degeneration
Study evaluates Macular Health supplement in dry age-related macular degeneration - Alzheimer Disease
Coalition calls U.S. FDA's new focus on neurological diseases a positive first step - Ankylosing Spondylitis
Data shows Enbrel provides sustained clinical improvements for people with ankylosing spondylitis - Antibacterial Agents
Oragenics pursues licensing of oral probiotic mouthrinse following positive clinical results - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
